Hangzhou Tigermed Consulting Co., Ltd. announced that Ms. Cao Xiaochun (" Ms. Cao ") has tendered her resignation as the chief financial officer of the Company with effect from October 21, 2022 so that she can devote more time to serve the Board and focus on the work as a general manager. Ms. Cao will remain as executive Director and general manager of the Company, and she has confirmed that she has no disagreement with the Board and there is no matter that needs to be brought to the attention of the holders of securities of the Company in respect of her resignation as the Chief Financial Officer. The Board is pleased to announced that Ms. Yang Chengcheng ("Ms. Yang") has been appointed as the Chief Financial Officer with effect from October 21, 2022.

Ms. Yang, aged 48, joined the Company in September 2022. Prior to joining the Company, she had worked in management positions such as senior auditor of PricewaterhouseCoopers, assistant financial controller of Otis Electric Elevator Co., Ltd. (formerly known as Hangzhou Xizi Otis Co., Ltd.), financial controller of Xizi Elevator Group Co., Ltd., director, financial controller and investment officer of Baida Group Co., Ltd., financial controller of Pacific Shuanglin Bio-pharmacy Co., Ltd. and managing director, financial controller and person-in-charge of risk control and post investment of Zhejiang United Investment Group Co., Ltd. Ms. Yang is familiar with domestic and overseas accounting and taxation standards and specializes in finance, taxation, risk control and operation management. She has over 20 years of experience in financial management as well as investment and financing and capital operation of listed companies.

Ms. Yang holds a master's degree of business administration from Zhejiang University.